194 related articles for article (PubMed ID: 11176048)
1. Basal cell carcinomas are populated by melanocytes and Langerhans [correction of Langerhan's] cells.
Florell SR; Zone JJ; Gerwels JW
Am J Dermatopathol; 2001 Feb; 23(1):24-8. PubMed ID: 11176048
[TBL] [Abstract][Full Text] [Related]
2. A rare case of invasive melanoma likely arising from passenger melanocytes of a basal cell carcinoma.
Paladichuk H; Talbott LB
J Cutan Pathol; 2020 Dec; 47(12):1192-1195. PubMed ID: 32716592
[TBL] [Abstract][Full Text] [Related]
3. A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma.
Belisle A; Gautier MS; Ghozali F; Plantier F; Wechsler J
Am J Dermatopathol; 2005 Aug; 27(4):319-21. PubMed ID: 16121053
[TBL] [Abstract][Full Text] [Related]
4. Collision tumor of malignant skin cancers: a case of melanoma in basal cell carcinoma.
Papa G; Grandi G; Pascone M
Pathol Res Pract; 2006; 202(9):691-4. PubMed ID: 16876964
[TBL] [Abstract][Full Text] [Related]
5. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical comparison of cutaneous lymphadenoma, trichoblastoma, and basal cell carcinoma: support for classification of lymphadenoma as a variant of trichoblastoma.
McNiff JM; Eisen RN; Glusac EJ
J Cutan Pathol; 1999 Mar; 26(3):119-24. PubMed ID: 10235376
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma in situ colonizing basal cell carcinoma. A simulator of invasive melanoma.
Burkhalter A; White WL
Am J Dermatopathol; 1997 Jun; 19(3):303-7. PubMed ID: 9185921
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
9. Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion.
Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2007 Dec; 29(6):566-7. PubMed ID: 18032954
[TBL] [Abstract][Full Text] [Related]
10. Pigmented basal cell carcinoma: increased melanin or increased melanocytes?
Brankov N; Prodanovic EM; Hurley MY
J Cutan Pathol; 2016 Dec; 43(12):1139-1142. PubMed ID: 27612950
[TBL] [Abstract][Full Text] [Related]
11. A colonization of basal cell carcinoma by malignant melanoma in situ resembling a malignant basomelanocytic tumor.
Goeser M; DiMaio DJ
Am J Dermatopathol; 2014 Nov; 36(11):e179-82. PubMed ID: 24752214
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma metastatic to a basal cell carcinoma simulating the pattern of a basomelanocytic tumor.
Busam KJ; Halpern A; Marghoob AA
Am J Surg Pathol; 2006 Jan; 30(1):133-6. PubMed ID: 16330954
[TBL] [Abstract][Full Text] [Related]
13. Melanocytes express 3G5 surface antigen.
Fiedler E; Nayak RC; Marsch WCh; Helmbold P
Am J Dermatopathol; 2004 Jun; 26(3):200-4. PubMed ID: 15166506
[TBL] [Abstract][Full Text] [Related]
14. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis.
Weyers W; Bonczkowitz M; Weyers I; Bittinger A; Schill WB
Am J Dermatopathol; 1996 Dec; 18(6):560-6. PubMed ID: 8989926
[TBL] [Abstract][Full Text] [Related]
15. Combined high-grade basal cell carcinoma and malignant melanoma of the skin ("malignant basomelanocytic tumor"): report of two cases and review of the literature.
Rodriguez J; Nonaka D; Kuhn E; Reichel M; Rosai J
Am J Dermatopathol; 2005 Aug; 27(4):314-8. PubMed ID: 16121052
[TBL] [Abstract][Full Text] [Related]
16. Preferentially expressed antigen in melanoma expression in nonmelanoma skin cancers and melanocytes in surrounding skin.
Elsensohn A; Hanson J; Ferringer T
J Cutan Pathol; 2021 Sep; 48(9):1150-1155. PubMed ID: 33719089
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and immunohistochemical features of pigmented Basal cell carcinomas of the eyelids.
Kirzhner M; Jakobiec FA
Am J Ophthalmol; 2012 Feb; 153(2):242-252.e2. PubMed ID: 21982104
[TBL] [Abstract][Full Text] [Related]
18. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
19. Pan-cytokeratin markers for rapid frozen section immunocytochemistry from head and facial Mohs cases of basal cell carcinoma: a comparison and evaluation to determine the marker of choice.
Orchard GE; Wojcik K; Shams F; Georgaki E; Quaye CJ; Fernando P; Torres J; Ismail F; Shams M
Br J Biomed Sci; 2015; 72(2):61-6. PubMed ID: 26126321
[TBL] [Abstract][Full Text] [Related]
20. Melanocytic aggregates with unique morphology associated with regression of basal cell carcinoma.
Jackson CR; Sriharan A; Momtahen S; Seidel GD; Felty CC; Ruby KN; Yan S
J Cutan Pathol; 2020 Mar; 47(3):219-225. PubMed ID: 31693192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
